MaxCyte MXCT Business Segments — Operating Expenses

Similar metrics at other companies

ERIIEmerging Technologies — Operating Expenses

$5.05M+27.0%

ECORBioelectronic Innovations — Operating Expenses

$13.68M+43.6%

NOVEnergy Equipments — Operating Expenses

$1.09B+7.8%

TGE

TGENEnergy Production — Operating Expenses

$42.55K+158%

GEOSEnergy Solutions — Operating Expenses

$3.16M-11.1%

CSPITechnology Solutions — Operating Expenses

$3.46M+6.1%

Questions, answered.

What is MaxCyte's business segments — operating expenses?

MaxCyte (MXCT) reported business segments — operating expenses of $14.27M in Q1 2026.

How has MaxCyte's business segments — operating expenses changed year-over-year?

MaxCyte's business segments — operating expenses decreased by 32.7% year-over-year, from $21.19M to $14.27M.

What is the long-term trend for MaxCyte's business segments — operating expenses?

Over 2 years (2023 to 2025), MaxCyte's business segments — operating expenses has grown at a -3.7% compound annual growth rate (CAGR), from $84.85M to $78.7M.

What does business segments — operating expenses mean?

This metric represents the total costs incurred by the cell engineering technology segment to support its day-to-day business operations, excluding the direct cost of goods sold. It encompasses essential functional expenditures such as research and development, sales and marketing, and general administrative overhead. Monitoring this figure helps investors assess the operational efficiency and cost structure required to maintain the segment's market position.